Skip to content

Comparison of the effectiveness of traditional transcranial stimulation with multichannel extracranial stimulation on improving the clinical symptoms of people with major depression and improving their executive function

Optimization of transcranial stimulation protocol with direct flow on executive functions and reduction of symptoms in people with major depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210517051330N1
Enrollment
60
Registered
2021-06-20
Start date
2021-06-22
Completion date
Unknown
Last updated
2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depression. Major depressive disorder, single episode, unspecified

Interventions

Intervention 1: Intervention group 1: Traditional transcranial stimulation, in the treatment of direct current stimulation from the skull, two electrodes, one positive pole and the other negative pole

Sponsors

Zanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Having diagnostic criteria for unipolar MDD based on psychiatrist diagnosis and clinical interview Age range between 75-18 years Failure to treat with at least one antidepressant Do not take antidepressants now or have a consistent medication regimen for the past 4 weeks Score 17 on the Hamilton Depression Inventory Willingness to participate in research Conscious consent to participate in research Have the opportunity to participate in evaluation and treatment sessions (daily) (in terms of distance, cost, etc.)

Exclusion criteria

Exclusion criteria: Diagnosis of bipolar disorder Diagnosis of substance use or alcohol Detection of dementia Diagnosis of personality disorder Diagnosis of brain injury, stroke or brain tumor Existence or history of psychosis Diagnosis of epilepsy or history of loss of consciousness Pregnancy Contraindications to the use of tDCS (cranial plates), such as those using a pacemaker. Currently or in the last 4 weeks the person has received another treatment for MDD (medication or other psychological treatments) Having diseases related to the scalp Having a history of head trauma and the presence of a device or tools in the head

Design outcomes

Primary

MeasureTime frame
Percentage of people whose Beck questionnaire score is above 20. Timepoint: Measurement of depression before the intervention, in the tenth session of the intervention, after the intervention, one-month follow-up and three months after the intervention. Method of measurement: Beck Questionnaire.;Percentage of people whose Hamilton questionnaire score is above 17. Timepoint: Measurement before intervention, after the intervention, one-month follow-up and three months after the intervention. Method of measurement: Hamilton Depression Test.;Depression Score on the Montgomery–Åsberg Depression Rating Scale. Timepoint: Measurements before the intervention, after the intervention.one-month follow-up and three months after the intervention. Method of measurement: Montgomery–Åsberg Depression Rating Scale.;Cognitive test score in cantab test. Timepoint: Measurements before the intervention, after the intervention.one-month follow-up and three months after the intervention. Method of measurement: cantab test.;Analyze the electroencephalography results. Timepoint: Measurements before the intervention, after the intervention. Method of measurement: Electroencephalography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarzieh Abdi

Zanjan University of Medical Sciences

Marziehabdi@zums.ac.ir+98 922 486 3706

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Apr 4, 2026